• LINC02870 Drives HCC Progression via EIF4G1-Mediated SNAIL T

  2026-06-29

  This study identifies the long non-coding RNA LINC02870 as a potent oncogenic driver in hepatocellular carcinoma (HCC), acting through a novel mechanism that enhances SNAIL translation via interaction with EIF4G1. The findings illuminate a new regulatory axis in HBV-related HCC progression and offer a foundation for future molecular targeting strategies.

• ARCA-Capped mRNA Synthesis: Beyond Yield to Functional Preci

  2026-06-29

  Explore how the HyperScribe Co-transcription mRNA Synthesis Kit Plus enables not just high-yield but functionally optimized ARCA-capped mRNA, with new insights into translational efficiency and immunogenicity for advanced applications.

• PRINT: RNA-Mediated Site-Specific Transgene Insertion in Hum

  2026-06-28

  The reference study introduces PRINT, a precise RNA-mediated approach for inserting transgenes into human safe-harbor loci by harnessing eukaryotic retroelement proteins. This method enables site-specific, scalable, and minimized-risk genome engineering, offering new possibilities for therapeutic gene insertion.

• Talabostat Mesylate (PT-100): Specific DPP4/FAP Inhibition i

  2026-06-27

  Talabostat mesylate (PT-100) is a potent, orally active inhibitor of DPP4 and FAP, enabling targeted modulation of tumor microenvironments and immune responses. Its specificity and solubility profile support reproducible cell-based and in vivo assays. Evidence highlights distinct effects in primary keratinocytes and FAP-expressing cancer models.

• Redefining Cell Viability Assessment: CCK-8 in Translational

  2026-06-26

  Explore how the Cell Counting Kit-8 (CCK-8) is reshaping cell viability and cytotoxicity assays, bridging mechanistic insight with strategic guidance for translational researchers. This article uniquely contextualizes CCK-8 within the current landscape of food safety, machine learning-driven risk stratification, and next-generation mechanistic validation, building upon recent advances in genotoxicity assessment. Go beyond standard product overviews with protocol recommendations, competitive insights, and a visionary perspective tailored for the future of precision toxicology.

• ETS1 Regulates SUMOylation-Dependent Mitophagy in BPD Models

  2026-06-26

  This study identifies ETS1 as a key transcriptional regulator that mitigates bronchopulmonary dysplasia (BPD) by modulating the SENP2/HSPA8/FUNDC1 axis and suppressing mitochondrial damage-induced mitophagy. These findings highlight the therapeutic potential of targeting sumoylation-dependent pathways in neonatal lung injury.

• Syringin Enhances Sunitinib Efficacy in Renal Cell Carcinoma

  2026-06-25

  This study identifies Syringin, a natural product, as a novel sensitizer of Sunitinib in renal cell carcinoma (RCC) by targeting the EGFR/PI3K/Akt pathway. The findings offer mechanistic insight into overcoming Sunitinib resistance and highlight feasible combinatorial strategies for RCC research.

• EdU Imaging Kits (Cy3): Advancing Fibroblast Proliferation R

  2026-06-25

  Explore how EdU Imaging Kits (Cy3) empower sensitive detection of fibroblast proliferation and DNA synthesis, with unique insights into environmental toxicity research. This article reveals practical protocol guidance and critical findings for cell cycle S-phase DNA synthesis measurement.

• Digestive Metabolomics of Withania somnifera: LC–MS/MS Insig

  2026-06-24

  This study pioneers a metabolomics-driven approach to unravel how Withania somnifera (ashwagandha) bioactives transform during simulated human digestion. By applying advanced LC–MS/MS profiling and molecular networking, the paper identifies selective stability and transformation patterns among key withanolides—informing future in vitro modeling and preclinical botanical pharmacology.

• Estradiol (SKU A8425): Reliable Estrogen Receptor Signaling

  2026-06-23

  This article addresses key laboratory challenges in cell viability, proliferation, and cytotoxicity assays involving estrogen receptor signaling. By examining real-world scenarios, it demonstrates how Estradiol (SKU A8425) from APExBIO offers reproducible, data-backed solutions for advanced research workflows.

• Lypressin Acetate: Precision Peptide for Multi-Receptor Modu

  2026-06-23

  Explore the advanced pharmacology of Lypressin acetate, a lysine vasopressin analog, with a focus on its multi-receptor action and evolving applications. This expert review uniquely bridges complex assay design and translational potential in endocrine and antiviral research.

• Solving Real-World Assay Challenges with L1023 Anti-Cancer C

  2026-06-22

  This evidence-based article provides biomedical researchers and lab technicians with scenario-driven solutions using the DiscoveryProbe™ Anti-cancer Compound Library (SKU: L1023). It explores assay optimization, compound stability, and data reproducibility, highlighting how SKU L1023 streamlines high-throughput screening of anti-cancer agents with validated quality and workflow efficiency.

• PYR-41: Inhibitor of Ubiquitin-Activating Enzyme E1 in Pathw

  2026-06-22

  PYR-41, a potent inhibitor of Ubiquitin-Activating Enzyme E1, enables selective and reversible control over protein degradation and immune signaling pathways in both cellular and in vivo models. Its unique mechanism empowers researchers to dissect ubiquitin-proteasome system dynamics, unravel NF-κB signaling, and model inflammation or apoptosis with precision.

• Palomid 529 (P529): Optimizing PI3K/Akt/mTOR Inhibition in C

  2026-06-21

  Palomid 529 (P529) delivers robust, dual inhibition of mTORC1 and mTORC2, enabling reproducible suppression of the PI3K/Akt/mTOR pathway in both cancer and neuroscience research. This guide translates the latest mechanistic insights into stepwise protocols and troubleshooting strategies, supporting advanced studies on metastasis, drug resistance, and radiotherapy enhancement.

• Indometacin Sodium: Bridging Mechanism to Translational Impa

  2026-06-20

  Explore the multifaceted translational applications of Indometacin Sodium Trihydrate, from its mechanistic roles in inflammation and pain pathways to its emerging significance in IVF protocols, tumor stroma modulation, and myelin regeneration. This thought-leadership article offers mechanistic insights, experimental guidance, and strategic foresight for researchers translating bench discoveries into meaningful clinical progress.

451 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page